Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock
CYCCP
CYCCP
3 hedge funds and large institutions have $114K invested in Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citigroup
New York
|
$10K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$15K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BBA
1
Baker Bros. Advisors
New York
| $89K | 13,253 | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $15K | 2,164 | +1 | +0% |
|
|
3
Citigroup
New York
| $10K | 1,481 | +1,481 | New |
|